Literature DB >> 16600297

Artemis phosphorylated by DNA-dependent protein kinase associates preferentially with discrete regions of chromatin.

Sébastien Soubeyrand1, Louise Pope, Régina De Chasseval, Dominique Gosselin, Fumin Dong, Jean-Pierre de Villartay, Robert J G Haché.   

Abstract

Artemis is a nuclear phosphoprotein required for genomic integrity whose phosphorylation is increased subsequent to DNA damage. Artemis phosphorylation by the DNA-dependent protein kinase (DNA-PK) and the association of Artemis with DNA-PK catalytic subunit (DNA-PKcs) have been proposed to be crucial for the variable, diversity, joining (V(D)J) reaction, genomic stability and cell survival in response to double-stranded DNA breaks. The exact nature of the effectors of Artemis phosphorylation is presently being debated. Here, we have delimited the interface on Artemis required for its association with DNA-PKcs and present the characterization of six DNA-PK phosphorylation sites on Artemis whose phosphorylation shows dependence on its association with DNA-PKcs and is induced by double-stranded DNA damage. Surprisingly, DNA-PKcs Artemis association appeared to be dispensable in a V(D)J recombination assay with stably integrated DNA substrates. Phosphorylation at two of the sites on Artemis, S516 and S645, was verified in vivo using phosphospecific antibodies. Basal Artemis S516 and S645 phosphorylation in vivo showed a significant dependence on DNA-PKcs association. However, regardless of its association with DNA-PKcs, phosphorylation of Artemis at both S516 and S645 was stimulated in response to the double-stranded DNA-damaging agent bleomycin, albeit to a lesser extent. This suggests that additional factors contribute to promote DNA damage-induced Artemis phosphorylation. Intriguingly, pS516/pS645 Artemis was concentrated in chromatin-associated nuclear foci in naïve cells. These foci were maintained upon DNA damage but failed to overlap with the damage-induced gammaH2AX. These results provide the expectation of a specific role for DNA-PK-phosphorylated Artemis in both naïve and damaged cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600297     DOI: 10.1016/j.jmb.2006.02.061

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

Review 1.  Coordination of DNA-PK activation and nuclease processing of DNA termini in NHEJ.

Authors:  Katherine S Pawelczak; Sara M Bennett; John J Turchi
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

2.  Autoinhibition of the Nuclease ARTEMIS Is Mediated by a Physical Interaction between Its Catalytic and C-terminal Domains.

Authors:  Doris Niewolik; Ingrid Peter; Carmen Butscher; Klaus Schwarz
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

3.  Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B.

Authors:  Liyi Geng; Xiaoshan Zhang; Shu Zheng; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

4.  Alterations of DNA damage repair pathways resulting from JCV infection.

Authors:  Armine Darbinyan; Martyn K White; Selma Akan; Sujatha Radhakrishnan; Luis Del Valle; Shohreh Amini; Kamel Khalili
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 5.  Structural insights into NHEJ: building up an integrated picture of the dynamic DSB repair super complex, one component and interaction at a time.

Authors:  Gareth J Williams; Michal Hammel; Sarvan Kumar Radhakrishnan; Dale Ramsden; Susan P Lees-Miller; John A Tainer
Journal:  DNA Repair (Amst)       Date:  2014-03-20

Review 6.  Nonhomologous end joining: a good solution for bad ends.

Authors:  Crystal A Waters; Natasha T Strande; David W Wyatt; John M Pryor; Dale A Ramsden
Journal:  DNA Repair (Amst)       Date:  2014-03-14

Review 7.  The multifunctional SNM1 gene family: not just nucleases.

Authors:  Yiyi Yan; Shamima Akhter; Xiaoshan Zhang; Randy Legerski
Journal:  Future Oncol       Date:  2010-06       Impact factor: 3.404

Review 8.  Reversion of the ErbB malignant phenotype and the DNA damage response.

Authors:  E Aaron Runkle; Hongtao Zhang; Zheng Cai; Zhiqiang Zhu; Barry L Karger; Shiaw-Lin Wu; Donald M O'Rourke; Zhaocai Zhou; Qiang Wang; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2012-09-27       Impact factor: 3.362

9.  Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.

Authors:  Kerstin Felgentreff; Yu Nee Lee; Francesco Frugoni; Likun Du; Mirjam van der Burg; Silvia Giliani; Ilhan Tezcan; Ismail Reisli; Ester Mejstrikova; Jean-Pierre de Villartay; Barry P Sleckman; John Manis; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2015-04-25       Impact factor: 10.793

10.  Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability.

Authors:  Ying Huang; William Giblin; Martina Kubec; Gerwin Westfield; Jordan St Charles; Laurel Chadde; Stephanie Kraftson; JoAnn Sekiguchi
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.